I also have shares in Telix pharmaceuticals which is another company i am a big believer in, maybe moving forward i go with TLX and PAR?
It sounds like PAR have a viable product here not far from getting final approval and are further forward in their progamme, Mesoblast lung cancer treatment seems further off from what i have read, and even their COVID treatment trials are still only in the very early stages, and there seems to be a lot of other companies also after that COVID treatment.
PAR - Deal me in, page-11
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |